A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery.

A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery. Pharmacoeconomics. 2004; 22(9):605-20.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Anticoagulants
Clinical Trials as Topic
Cohort Studies
Cost-Benefit Analysis
Decision Support Techniques
Enoxaparin
Health Care Costs
Hip Fractures
Humans
Models, Economic
Orthopedic Procedures
Polysaccharides
Treatment Outcome
Venous Thrombosis

authors with profiles

Gary E Raskob